Al Kraus

Al Kraus, listed as board member, appears in our data through filings on Cytosorbents Corp shares, published by SEC (Form 4). Between 18 June 2014 and 6 February 2023, the trades on record add up to 111 filings.

The open-market side counts 1 purchase for €9,293 alongside 52 sales for €2.0M. Netting one side against the other leaves €2.0M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 4 share grants and 54 option exercises.

On 8 February 2023 came the latest disclosure, an option exercise for €29k in Cytosorbents Corp. The latest purchase dates back some time: it was published 1,645 days ago, on 9 May 2022. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.